Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-13

Clinical Trial Update: Optimal Timing of Zoster Vaccine After Zoster Illness [NA]

View source ↗

Summary

A clinical trial update discusses the best timing for administering the zoster vaccine after a shingles infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Shingrix (recombinant zoster vaccine, adjuvanted)
  • Zostavax (Varicella zoster vaccine live)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Shingles | NA | Status: COMPLETED